ES8801695A1 - Procedimiento de obtencion de complejos macropoliciclicos de tierras ratas - Google Patents

Procedimiento de obtencion de complejos macropoliciclicos de tierras ratas

Info

Publication number
ES8801695A1
ES8801695A1 ES557485A ES557485A ES8801695A1 ES 8801695 A1 ES8801695 A1 ES 8801695A1 ES 557485 A ES557485 A ES 557485A ES 557485 A ES557485 A ES 557485A ES 8801695 A1 ES8801695 A1 ES 8801695A1
Authority
ES
Spain
Prior art keywords
rare earth
application
earth metals
fluorescent labels
macropolycyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557485A
Other languages
English (en)
Other versions
ES557485A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Publication of ES557485A0 publication Critical patent/ES557485A0/es
Publication of ES8801695A1 publication Critical patent/ES8801695A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
    • C09K11/08—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials
    • C09K11/77—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials containing rare earth metals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/40—Rare earth chelates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPLEJOS MACROPOLICICLICOS DE TIERRAS RARAS. CONSISTE EN HACER REACCIONAR UN COMPUESTO DONADOR DE CATIONES DE TIERRAS RARAS, CON UN COMPUESTO MACROPOLICICLICO, DE FORMULA GENERAL (I), EN LA QUE Z ES UN ATOMO DE 3 O 4 VALENCIAS; R ES NADA O REPRESENTA HIDROGENO O UN GRUPO HIDROXI; LOS RADICALES BIVALENTES A, B Y C REPRESENTAN INDEPENDIENTEMENTE ENTRE SI CADENAS HIDROCARBONADAS QUE CONTIENEN EVENTUALMENTE UNO O VARIOS HETEROATOMOS Y ESTAN EVENTUALMENTE INTERRUMPIDAS POR UN HETEROMACROCICLO. DE APLICACION COMO MARCADORES EN LOS DOSIFICADORES INMUNOLOGICOS.
ES557485A 1984-09-26 1987-04-01 Procedimiento de obtencion de complejos macropoliciclicos de tierras ratas Expired ES8801695A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8414799A FR2570703B1 (fr) 1984-09-26 1984-09-26 Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents

Publications (2)

Publication Number Publication Date
ES557485A0 ES557485A0 (es) 1988-02-16
ES8801695A1 true ES8801695A1 (es) 1988-02-16

Family

ID=9308106

Family Applications (3)

Application Number Title Priority Date Filing Date
ES547294A Expired ES8706792A1 (es) 1984-09-26 1985-09-25 Procedimiento de exaltacion de la fluorescencia de un ion detierra rara
ES557485A Expired ES8801695A1 (es) 1984-09-26 1987-04-01 Procedimiento de obtencion de complejos macropoliciclicos de tierras ratas
ES557486A Expired ES8801938A1 (es) 1984-09-26 1987-04-01 Procedimiento para la obtencion de comopuestos macropoliciclicos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES547294A Expired ES8706792A1 (es) 1984-09-26 1985-09-25 Procedimiento de exaltacion de la fluorescencia de un ion detierra rara

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557486A Expired ES8801938A1 (es) 1984-09-26 1987-04-01 Procedimiento para la obtencion de comopuestos macropoliciclicos

Country Status (9)

Country Link
US (1) US4927923A (es)
EP (1) EP0180492B1 (es)
JP (3) JPH0655741B2 (es)
KR (1) KR930008210B1 (es)
AT (1) ATE90084T1 (es)
CA (1) CA1329593C (es)
DE (1) DE3587380T2 (es)
ES (3) ES8706792A1 (es)
FR (1) FR2570703B1 (es)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5220012A (en) * 1984-09-26 1993-06-15 Compagnie Oris Industrie Sa Macropolycyclic rare earth complexes and application as fluorescent tracers
SE454781B (sv) * 1986-10-17 1988-05-30 Wallac Oy Hybridiseringsforfarande for detektion av polynukleotidsekvens
US5162508A (en) * 1987-12-18 1992-11-10 Compagnie Oris Industrie Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
FR2624862B1 (fr) * 1987-12-18 1990-06-08 Oris Ind Cryptates de terres rares, procedes d'obtention, intermediaires de synthese et application a titre de marqueurs fluorescents
US5134232A (en) * 1988-11-14 1992-07-28 The Regents Of The University Of California Fluorescent indicator dyes for alkali metal cations
US5094759A (en) * 1989-03-17 1992-03-10 The University Of Southern Mississippi Method of water treatment using 2,6-substituted aminopyridines and polymer derived therefrom
US5216134A (en) * 1989-10-23 1993-06-01 Wallac Oy Spectrofluorometric method and compounds that are of value for the method
FR2664699B1 (fr) * 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
WO1992005804A1 (en) * 1990-09-27 1992-04-16 Brunswick Corporation Chelating agents
EP0493745A1 (en) * 1990-12-21 1992-07-08 Dojindo Laboratories Fluorescent compound, complex, reagent, and specific binding assay employing said reagent
CA2072934C (en) * 1991-07-19 2007-08-28 Karl William Aston Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
FR2680787B1 (fr) * 1991-08-30 1994-11-04 Cis Bio Int Complexes macrocycliques de terres rares et leur utilisation pour reduire les interferences dans un dosage par fluorescence.
WO1993011433A1 (en) * 1991-12-05 1993-06-10 Wallac Oy Luminescent lanthanide chelates
US5417959A (en) * 1993-10-04 1995-05-23 Mallinckrodt Medical, Inc. Functionalized aza-crytand ligands for diagnostic imaging applications
AU1694895A (en) * 1994-01-28 1995-08-15 Mallinckrodt Medical, Inc. Functionalized aza-bimacrocyclic ligands for imaging applications
US6329139B1 (en) 1995-04-25 2001-12-11 Discovery Partners International Automated sorting system for matrices with memory
US6017496A (en) 1995-06-07 2000-01-25 Irori Matrices with memories and uses thereof
US5792330A (en) * 1995-05-31 1998-08-11 Board Of Regents, The University Of Texas System Lanthanide metal cations for concurrent detection and separation in capillary electrophoresis
FR2768817B1 (fr) * 1997-09-19 1999-12-10 Cis Bio Int Methode homogene pour la detection et/ou la determination de l'activite phosphorylante d'un materiel biologique
FR2769315B1 (fr) * 1997-10-03 2001-06-08 Cis Bio Int Conjugues fluorescents de nucleosides ou de nucleotides, leur procede de preparation et leur utilisation
JP2002507410A (ja) 1998-03-27 2002-03-12 プロルーム・リミテッド ルシフェラーゼ、蛍光タンパク質、ルシフェラーゼおよび蛍光タンパク質をコードする核酸および、診断、高処理スクリーニングおよび新規アイテムにおけるその使用
EP1925320A3 (en) 1998-03-27 2008-09-03 Prolume, Ltd. Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
US7109315B2 (en) * 2000-03-15 2006-09-19 Bruce J. Bryan Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
FR2809817B1 (fr) 2000-06-02 2003-08-15 Cis Bio Int Procede de detection de presence d'un liquide dans un melange
FR2810406B1 (fr) * 2000-06-15 2002-09-20 Cis Bio Int Nouveaux cryptates de terre rare peu sensibles a l'extinction de fluorescence
US20050042623A1 (en) * 2002-10-30 2005-02-24 Dana Ault-Riche Systems for capture and analysis of biological particles and methods using the systems
WO2004071641A2 (en) * 2003-02-10 2004-08-26 Pointilliste, Inc. Self-assembling arrays and uses thereof
US7018851B2 (en) * 2003-02-13 2006-03-28 Innotrac Diagnostics Oy Biospecific binding reactants labeled with new luminescent lanthanide chelates and their use
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
US7727752B2 (en) * 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US20050064485A1 (en) * 2003-09-12 2005-03-24 Kurt Vogel Multiplex binding and activity assays
US20050095648A1 (en) * 2003-10-30 2005-05-05 Mario Geysen Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
EP1684808B1 (en) * 2003-11-07 2013-01-09 Newport Instruments A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
JP2008514900A (ja) * 2004-07-30 2008-05-08 アデザ・バイオメデイカル・コーポレイシヨン 疾病および他の状態のマーカーとしての癌胎児性フィブロネクチンならびに癌胎児性フィブロネクチンの検出のための方法
FR2878850B1 (fr) * 2004-12-02 2008-10-31 Cis Bio Internat Sa Derives de l'inositol-1-phosphate
DE102005020384A1 (de) * 2005-05-02 2006-11-09 Therainvention Gmbh Spektroskopisches Verfahren zum Nachweis von Analyten
JP4559922B2 (ja) 2005-06-21 2010-10-13 株式会社東芝 蛍光性錯体及びそれを用いた照明装置
FR2890174B1 (fr) * 2005-08-30 2009-04-24 Cis Bio Internat Sa Procede pour la mise en evidence d'un processus biologique par mesure d'un fret
FR2890446B1 (fr) 2005-09-05 2008-04-18 Cis Bio Internat Sa Methode de detection d'interaction intracellulaire entre bio-molecules
JP2009513681A (ja) 2005-10-28 2009-04-02 インヴィトロジェン コーポレーション キナーゼおよびユビキネーションアッセイ法
US7482444B2 (en) * 2006-03-13 2009-01-27 Wallac Oy Terminating substrates for DNA polymerases
DE102006021406B4 (de) 2006-05-08 2008-08-07 B.R.A.H.M.S Aktiengesellschaft In vitro Verfahren zur Früherkennung von arznei- und suchtmittelinduzierten Leberschäden und zur Erkennung der bereits erreichten Stufe der Leberschädigung
WO2008020113A1 (en) 2006-08-18 2008-02-21 Abacus Diagnostica Oy Luminescent lanthanide labelling reagents and their use
US20090306368A1 (en) * 2006-11-27 2009-12-10 Sumitomo Chemical Company, Limited Polynuclear complex
DE102007009751A1 (de) 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
DE102007022367A1 (de) 2007-05-07 2008-11-20 B.R.A.H.M.S Ag Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
EP2316035A2 (en) * 2008-07-16 2011-05-04 Radiometer Medical ApS Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
FR2934684B1 (fr) 2008-07-31 2012-11-16 Cis Bio Int Methode de detection de l'internalisation de proteines membranaires.
FR2936245B1 (fr) 2008-09-23 2012-07-06 Cis Bio Int Nouveaux substrats d'o6-alkylguanine-adn alkyltransferase et ses mutants.
FR2940286B1 (fr) 2008-12-19 2011-04-08 Cis Bio Int Nouveaux cryptates de terres rares comportant un motif tetraazatriphenylene
FI20090100A0 (fi) 2009-03-16 2009-03-16 Wallac Oy Biotinidaasimääritys
WO2010125314A1 (fr) 2009-04-30 2010-11-04 Cis-Bio International Procede de detection de composes modulateurs de dimeres de proteines membranaires a domaine vft
FR2949156B1 (fr) 2009-08-13 2016-04-15 Cis-Bio Int Methode de determination de la liaison d'un compose donne a un recepteur membranaire
FR2977674B1 (fr) 2011-07-06 2015-08-14 Cisbio Bioassays Methode amelioree de detection et/ou de quantification d'un analyte present a la surface d'une cellule
FR2978149B1 (fr) 2011-07-18 2014-01-10 Cisbio Bioassays Nouveaux agents complexants et complexes de lanthanide correspondant, et leur utilisation comme marqueurs luminescents
FR2980271B1 (fr) 2011-09-16 2013-10-11 Cisbio Bioassays Procede de determination de la glycosylation d'un anticorps
WO2013042120A2 (en) 2011-09-19 2013-03-28 Proteologics Ltd Synthetic ubiquitins and use thereof in drug screening assays
WO2013124544A1 (fr) 2012-02-22 2013-08-29 Cisbio Bioassays Procede de normalisation de la luminescence emise par un milieu de mesure.
FR2988174B1 (fr) 2012-03-19 2014-04-25 Cisbio Bioassays Procede de determination de la capacite d'un anticorps a maintenir des cellules a proximite l'une de l'autre
WO2014136115A1 (en) 2013-03-07 2014-09-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Non-selfabsorbing luminescent solar concentrator
FR3004189B1 (fr) 2013-04-04 2015-09-04 Ecole Norm Superieure Lyon Complexes de lanthanide comprenant au moins deux groupes betaines, utiles comme marqueurs luminescents
FR3032797B1 (fr) 2015-02-13 2017-03-03 Cisbio Bioassays Procede de quantification d'une proteine d'interet presente dans un echantillon biologique
JP6944449B2 (ja) 2015-11-27 2021-10-06 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 対象の細胞外液量状態のマーカーとしてのＭＲ−ｐｒｏＡＤＭ
FR3045053B1 (fr) 2015-12-09 2018-01-05 Cisbio Bioassays Agents complexants hydrosolubles a base de triazapyridinophane et complexes de lanthanide fluorescents correspondants
CA3010895A1 (en) 2016-01-21 2017-07-27 SeLux Diagnostics, Inc. Methods for rapid antimicrobial susceptibility testing
US9834808B2 (en) 2016-01-21 2017-12-05 SeLux Diagnostics, Inc. Methods for rapid antibiotic susceptibility testing
EP3497451B1 (en) 2016-08-09 2025-06-18 B.R.A.H.M.S GmbH Histones and/or proadm as markers indicating an adverse event
US20190178897A1 (en) 2016-08-09 2019-06-13 B.R.A.H.M.S Gmbh Histones and/or proadm as markers indicating organ dysfunction
EP3555127B1 (en) 2016-12-16 2024-12-18 H. Lundbeck A/S Agents, uses and methods
WO2018119439A1 (en) 2016-12-23 2018-06-28 SeLux Diagnostics, Inc. Methods for improved rapid antimicrobial susceptibility testing
ES2944613T3 (es) 2017-02-02 2023-06-22 Brahms Gmbh proADM y/o histonas como marcadores indicadores de un acontecimiento adverso
EP3631460B1 (en) 2017-05-31 2023-11-15 B.R.A.H.M.S GmbH Mmp-8 as a marker for identifying infectious disease
FR3067349B1 (fr) 2017-06-12 2020-12-04 Cisbio Bioassays Nouveaux agents mono et di-antennes complexants hydrosolubles et complexes de lanthanide correspondants
FR3067712B1 (fr) 2017-06-14 2019-08-02 Cisbio Bioassays Nouveaux agents complexants de type trimethoxyphenyl pyridine hydrosolubles et complexes de lanthanide correspondants
FR3069644B1 (fr) 2017-07-28 2024-07-12 Cisbio Bioassays Methode pour mesurer la modulation de l'activation d'un recepteur couple a une proteine g
CA3075440A1 (en) 2017-09-13 2019-03-21 B.R.A.H.M.S Gmbh Pro-adm as a therapy monitoring marker for critcally ill patients
EP3502691A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Proadrenomedullin as indicator for renal replacement therapy in critically ill patients
US20200271666A1 (en) 2017-09-13 2020-08-27 B.R.A.H.M.S Gmbh Proadrenomedullin as indicator for renal replacement therapy in critically ill patients
CN111094981B (zh) 2017-09-13 2024-04-16 B.R.A.H.M.S有限公司 Pct和pro-adm作为监测抗生素治疗的标记物
US11327082B2 (en) 2017-09-13 2022-05-10 B.R.A.H.M.S Gmbh Proadrenomedullin as a marker for abnormal platelet levels
CN111656189A (zh) 2017-12-20 2020-09-11 B.R.A.H.M.S有限公司 基于合并症患者的降钙素原的抗生素疗法指导
WO2019122089A1 (en) 2017-12-20 2019-06-27 B.R.A.H.M.S Gmbh Antibiotic therapy guidance based on pro-adm
CN111630382A (zh) 2017-12-21 2020-09-04 H.隆德贝克有限公司 α-共核蛋白病的测定、方法和治疗
EP3578989A1 (en) 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients
FR3084365B1 (fr) 2018-07-27 2020-10-23 Cisbio Bioassays Anticorps a domaine unique qui se lient a la proteine g alpha
EP3608673A1 (en) 2018-08-08 2020-02-12 B.R.A.H.M.S GmbH Pro-adm for prognosing the risk of a medical condition requiring hospitalization in patients with symptoms of infectious disease
JP7640168B2 (ja) 2019-01-28 2025-03-05 ベー．エル．アー．ハー．エム．エス ゲーエムベーハー 夜尿症の患者の治療応答を予測する方法
FR3092172B1 (fr) 2019-01-30 2021-02-12 Cisbio Bioassays Méthode pour mesurer la modulation de l’activation d’un récepteur couplé à une protéine G avec des analogues du GTP
BR112021016597A2 (pt) 2019-02-21 2021-11-03 Brahms Gmbh Diagnóstico ou prognóstico de eventos adversos pós-cirúrgicos
EP3715851A1 (en) 2019-03-29 2020-09-30 B.R.A.H.M.S GmbH Prescription of remote patient management based on biomarkers
WO2020201078A1 (en) 2019-03-29 2020-10-08 B.R.A.H.M.S Gmbh Prescription of remote patient management based on biomarkers
AU2020340381A1 (en) 2019-08-27 2022-04-07 SeLux Diagnostics, Inc. Systems and methods for performing antimicrobial susceptibility testing
WO2021204770A1 (en) 2020-04-06 2021-10-14 B.R.A.H.M.S Gmbh Pro-adrenomedullin for prognosing disease progression in severe acute respiratory syndrome (sars)
US20230176074A1 (en) 2020-04-09 2023-06-08 B.R.A.H.M.S Gmbh Biomarkers for the diagnosis of respiratory tract infections
JP7851566B2 (ja) 2021-12-08 2026-04-27 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 早発性子癇前症の予後についてのバイオマーカー
CA3240914A1 (en) 2021-12-13 2023-06-22 Universite Laval Biomarkers for the prediction of preterm birth
CN120380346A (zh) 2022-12-08 2025-07-25 B.R.A.H.M.S有限公司 用于早发型先兆子痫预后的多个sFlt-1测量值
EP4710108A1 (en) 2023-05-12 2026-03-18 B.R.A.H.M.S GmbH Mid-regional pro-adrenomedullin immunoassay with monoclonal antibodies
WO2025078420A1 (en) 2023-10-09 2025-04-17 B.R.A.H.M.S Gmbh Biomarkers for therapy management and/or prognosing disease progression, severity and/or outcome for respiratory virus infections
WO2026013199A1 (en) 2024-07-12 2026-01-15 Cezanne S.A.S. Clinical immunoassay with early signal measurement

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888877A (en) * 1969-06-11 1975-06-10 Schering Corp Macrocyclic compounds and complexes thereof
US3847949A (en) * 1970-05-12 1974-11-12 Du Pont Macrocyclic hetero imine complexing agents
CA966127A (en) * 1970-05-12 1975-04-15 Marilyn H. Bromels Macrocyclic hetero imine complexing agents
US4156683A (en) * 1973-03-26 1979-05-29 Schering Corporation Complexes of macrocyclic compounds
US3966766A (en) * 1973-03-26 1976-06-29 Schering Corporation Monocyclic macrocyclic compounds and complexes thereof
US4058732A (en) * 1975-06-30 1977-11-15 Analytical Radiation Corporation Method and apparatus for improved analytical fluorescent spectroscopy
SE428332B (sv) * 1979-03-08 1983-06-20 Wallac Oy Forfarande for fluorescensspektroskopisk bestemning av biologiskt aktivt emne, sasom hapten, antikropp eller antigen
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
CA1205028A (en) * 1981-07-01 1986-05-27 Jerald C. Hinshaw Fluorescent chelates and labeled specific binding reagents prepared therefrom
DE3202779A1 (de) * 1982-01-28 1983-08-04 Merck Patent Gmbh, 6100 Darmstadt Kaliumreagens und verfahren zur bestimmung von kaliumionen
US4631119A (en) * 1983-11-23 1986-12-23 W. R. Grace & Co. Reversible, electrochemically-switched lariat ethers
US4659815A (en) * 1985-02-04 1987-04-21 The President And Trustees Of The Miami University Chromogenic aza-12-crown-4 ethers and method of using same for the detection of lithium
US4734376A (en) * 1985-02-04 1988-03-29 The President & Trustees Of The Miami University Process for the spectrophotometric measurement of lithium ion employing a chromogenic aza-12-crown-4- ether
GB8528804D0 (en) * 1985-11-22 1985-12-24 Amersham Int Plc Compounds

Also Published As

Publication number Publication date
US4927923A (en) 1990-05-22
ES557486A0 (es) 1988-03-01
ES8706792A1 (es) 1987-07-01
JPH0714935B2 (ja) 1995-02-22
CA1329593C (en) 1994-05-17
ES547294A0 (es) 1987-07-01
ES557485A0 (es) 1988-02-16
JPH06199858A (ja) 1994-07-19
JPH0655741B2 (ja) 1994-07-27
FR2570703A1 (fr) 1986-03-28
JPH0715471B2 (ja) 1995-02-22
EP0180492B1 (fr) 1993-06-02
FR2570703B1 (fr) 1988-07-08
JPH06184151A (ja) 1994-07-05
ES8801938A1 (es) 1988-03-01
KR860002553A (ko) 1986-04-26
ATE90084T1 (de) 1993-06-15
KR930008210B1 (ko) 1993-08-26
EP0180492A1 (fr) 1986-05-07
JPS6187680A (ja) 1986-05-06
DE3587380T2 (de) 1994-01-05
DE3587380D1 (es) 1993-07-08

Similar Documents

Publication Publication Date Title
ES8801695A1 (es) Procedimiento de obtencion de complejos macropoliciclicos de tierras ratas
ES2019942B3 (es) Tratamiento de formaciones subterraneas que contienen hierro.
UA39174C2 (uk) Асоціати депротонованої гіалуронової кислоти, спосіб одержання асоціатів депротонованої гіалуронової кислоти, фармацевтична композиція та спосіб одержання фармацевтичної композиції
DE3668514D1 (de) Seltenerd-eisen-bor-dauermagnet.
EP0185356A3 (en) Heat-resisting self-adhesive compound
BG103170A (en) Polymorphic form ii of finasteride and method for its preparation
GB9003939D0 (en) Sulphatase inhibitors
EP0151036A3 (en) N.m.r. shims
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
ZA859683B (en) Heat-curable composition
GR3031602T3 (en) Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase.
AU7183687A (en) Mine cooling
GB8530727D0 (en) Hook-&-eye assembly
FI863610A7 (fi) Menetelmä harvinaisten maametallimalmien rikastamiseksi.
SU1090060A1 (ru) Способ разработки нефтяной залежи
MY102059A (en) Naphthoxazines
ES2001247A6 (es) Un procedimiento para la preparacion de un derivado de gem-dihalo o tetrahalo-1,12-diamino-4,9-diaza-dodecano.
ES8507530A1 (es) Un procedimiento para la preparacion de aricoxicicloalcanolaminolaminoalquilen-aril-cetonas.
SU1241748A1 (ru) Способ разработки нефтяного месторождения
ES8504799A1 (es) Procedimiento de obtencion de piridopirimidinonas
GB8518524D0 (en) High contrast electroluminescent displays
AT379305B (de) Vitrine od. dgl.
SU1256381A1 (ru) Способ переработки редкоземельного концентрата
SU1271111A1 (ru) Сплав на основе алюминия
ES2006201A6 (es) Una composicion a base de cloruro de metileno.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20071231